With these two targets in mind, we hypothesized that nanoparticles synthesized with hyaluronic acid would also carry the Tris DBA-Pd payload to cells that express CD44 surface receptors, especially those cells which overexpress CD44 and IGF1R such as metastatic melanoma. The gene discussed is CD44; the disease is metastatic melanoma.